Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
China
· Delayed Price · Currency is CNY 19.63
-0.20 (-1.01%)
Mar 10, 2026, 9:25 AM CST
SHA:600529 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,027 | 13,226 | 17,101 | 16,989 | 18,847 | 26,119 | Upgrade
|
| Market Cap Growth | -19.88% | -22.66% | 0.66% | -9.86% | -27.84% | -12.46% | Upgrade
|
| Enterprise Value | 10,305 | 10,709 | 14,307 | 14,571 | 18,195 | 25,062 | Upgrade
|
| Last Close Price | 19.63 | 19.93 | 25.08 | 24.25 | 26.60 | 40.67 | Upgrade
|
| PE Ratio | 18.88 | 19.18 | 18.14 | 21.90 | 30.48 | 44.19 | Upgrade
|
| Forward PE | 13.15 | 12.76 | 15.24 | 17.24 | 22.72 | 39.31 | Upgrade
|
| PS Ratio | 2.91 | 2.96 | 3.34 | 3.41 | 4.50 | 6.74 | Upgrade
|
| PB Ratio | 1.57 | 1.60 | 2.14 | 2.26 | 2.71 | 5.59 | Upgrade
|
| P/TBV Ratio | 1.62 | 1.64 | 2.20 | 2.33 | 2.81 | 5.84 | Upgrade
|
| P/FCF Ratio | 37.75 | 38.33 | 33.06 | 45.13 | - | - | Upgrade
|
| P/OCF Ratio | 22.58 | 22.93 | 14.68 | 16.21 | 74.66 | 34.81 | Upgrade
|
| EV/Sales Ratio | 2.30 | 2.39 | 2.79 | 2.93 | 4.35 | 6.47 | Upgrade
|
| EV/EBITDA Ratio | 7.66 | 7.99 | 10.10 | 12.41 | 18.99 | 27.27 | Upgrade
|
| EV/EBIT Ratio | 10.84 | 11.27 | 13.87 | 17.17 | 27.45 | 36.94 | Upgrade
|
| EV/FCF Ratio | 29.86 | 31.04 | 27.66 | 38.71 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | - | 0 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | - | 0.00 | 0.01 | - | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.07 | - | 0.01 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.33 | -0.33 | -0.35 | -0.36 | -0.35 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.03 | -2.03 | -1.97 | -2.28 | -2.56 | -1.30 | Upgrade
|
| Net Debt / FCF Ratio | -7.89 | -7.89 | -5.39 | -7.12 | 5.34 | 20.27 | Upgrade
|
| Asset Turnover | 0.44 | 0.44 | 0.53 | 0.55 | 0.55 | 0.64 | Upgrade
|
| Inventory Turnover | 2.01 | 2.01 | 3.05 | 3.20 | 2.96 | 3.43 | Upgrade
|
| Quick Ratio | 2.64 | 2.64 | 2.26 | 2.54 | 2.27 | 1.43 | Upgrade
|
| Current Ratio | 3.76 | 3.76 | 2.99 | 3.21 | 3.02 | 1.99 | Upgrade
|
| Return on Equity (ROE) | 8.46% | 8.46% | 12.13% | 10.70% | 10.63% | 13.24% | Upgrade
|
| Return on Assets (ROA) | 5.89% | 5.89% | 6.63% | 5.86% | 5.45% | 7.05% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.05% | 14.59% | 17.39% | 15.43% | 14.48% | 18.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.30% | 11.30% | 12.70% | 11.20% | 9.40% | 14.30% | Upgrade
|
| Earnings Yield | 5.29% | 5.21% | 5.51% | 4.57% | 3.28% | 2.26% | Upgrade
|
| FCF Yield | 2.65% | 2.61% | 3.02% | 2.22% | -2.43% | -0.22% | Upgrade
|
| Dividend Yield | 3.03% | - | 2.47% | 1.65% | 1.13% | 0.74% | Upgrade
|
| Payout Ratio | 53.70% | 53.70% | 49.26% | 25.66% | 28.87% | 30.20% | Upgrade
|
| Buyback Yield / Dilution | 0.15% | 0.15% | -0.15% | -10.46% | -0.54% | -0.49% | Upgrade
|
| Total Shareholder Return | 3.17% | 0.15% | 2.32% | -8.81% | 0.59% | 0.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.